[HTML][HTML] Mucormycosis and COVID-19 pandemic: Clinical and diagnostic approach

A Azhar, WH Khan, PA Khan, K Alhosaini… - Journal of Infection and …, 2022 - Elsevier
The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is
yet to be controlled worldwide, especially in India. The second wave of coronavirus disease …

Nigella sativa L. and COVID-19: A Glance at The Anti-COVID-19 Chemical Constituents, Clinical Trials, Inventions, and Patent Literature

M Imran, SA Khan, Abida, MK Alshammari, SM Alkhaldi… - Molecules, 2022 - mdpi.com
COVID-19 has had an impact on human quality of life and economics. Scientists have been
identifying remedies for its prevention and treatment from all possible sources, including …

Risks of mucormycosis in the current Covid-19 pandemic: a clinical challenge in both immunocompromised and immunocompetent patients

P Monika, MN Chandraprabha - Molecular Biology Reports, 2022 - Springer
Abstract Mucormycosis, also called “Black Fungus”, is a new cause for worry in the current
Coronavirus disease 2019 (covid-19) pandemic. Mucormycosis is devasting due to its high …

Mucormycosis diagnosis revisited: current and emerging diagnostic methodologies for the invasive fungal infection

D Ponnaiyan, CM Anitha… - Experimental and …, 2022 - spandidos-publications.com
Mucormycosis, which is a life threatening condition, is one of the side effects experienced by
post-COVID-19 patients. Early identification and timely treatment are essential to stop the …

The effect of Ni gella sativa and vitamin D3 supplementation on the clinical outcome in COVID-19 patients: A randomized controlled clinical trial

SA Said, A Abdulbaset, AA El-Kholy… - Frontiers in …, 2022 - frontiersin.org
Background: The coronavirus disease 2019 (COVID-19) is a novel coronavirus that causes
severe infection in the respiratory system. Since the immune status plays an essential role in …

Diagnosis and management of mucormycosis in the dental clinic: A guide for oral health professionals in India

GS Aswal, R Rawat, D Dwivedi… - Journal of Family …, 2022 - journals.lww.com
With the current pandemic raging over the world, science and medicine is faced with hereto
with unfought enemies or less fought opponent in the form of viruses and consequently …

COVID-19-Associated Rhinocerebral Mucormycosis, an Incidental Finding or a Matter of Concern–Mixed-Method Systematic Review

M Andreescu, C Moldovan… - Infection and Drug …, 2024 - Taylor & Francis
With the advent of COVID-19, the number of patients diagnosed with mucormycosis has
increased, especially in developing countries. The reason behind this increase is that …

[HTML][HTML] In silico studies on Epicoccum spp. Secondary metabolites as potential drugs for mucormycosis

N Devadiga, M Fouillaud, L Dufossé, B Dmello… - Results in …, 2024 - Elsevier
Mucormycosis is a rare and severe form of fungal infection caused by some fungal species
belonged to mucormycetes that mainly infects skin but also eyes and other organs of the …

Epidemiologic threats and outcome of evolving COVID-19-associated mucormycosis from a referral hospital in Egypt

S Elserougy, M Abdel-Ghaffar, E Medhat… - The Journal of Infection …, 2024 - jidc.org
Introduction: The present study aimed to explore the epidemiologic threats and factors
associated with the coronavirus disease 2019 (COVID-19)-associated mucormycosis (CAM) …

[HTML][HTML] COVID-19-associated disseminated mucormycosis: An autopsy case report

D Kyuno, T Kubo, M Tsujiwaki, S Sugita… - World journal of …, 2022 - ncbi.nlm.nih.gov
BACKGROUND Reports of mucormycosis, an infectious disease that commonly affects
immunocompromised individuals, have increased during the ongoing coronavirus disease …